Correction in CELLINK’s Swedish press release
Earlier this morning at 07:00 (CET), CELLINK sent out a press release: CELLINK has entered into an agreement to acquire MatTek, the world-leading company in in vitro technology and alternative test methods for pharmaceuticals. The Swedish press release states the word “patent-protected”, this word shall be changed to “proprietary” as corrected reflected in the English press release. The information was submitted for publication, through the agency of the contact persons set out below, on March 10, 2021 at 09.16 (CET). For further information, please contact: Erik Gatenholm, CEO